Functional analysis of archaeal MBF1 by complementation studies in yeast

Dateibereich 27664

1,26 MB in 8 Dateien, zuletzt geändert am 30.07.2013

Dateiliste / Details

DateiDateien geändert amGröße
1745_6150_6_18.pdf01.06.2011 07:00:51995,3 KB
1745-6150-6-18-S1.PDF01.06.2011 07:00:5145,3 KB
1745-6150-6-18-S2.PDF01.06.2011 07:00:5120,2 KB
1745-6150-6-18-S3.PDF01.06.2011 07:00:5111,1 KB
1745-6150-6-18-S4.PDF01.06.2011 07:00:5115,5 KB
1745-6150-6-18-S5.PDF01.06.2011 07:00:5163,5 KB
1745-6150-6-18.xml01.06.2011 07:00:50129,3 KB
mets.xml01.06.2011 07:00:5110 KB
Background Multiprotein-bridging factor 1 (MBF1) is a transcriptional co-activator that bridges a sequence-specific activator (basic-leucine zipper (bZIP) like proteins (e.g. Gcn4 in yeast) or steroid/nuclear-hormone receptor family (e.g. FTZ-F1 in insect)) and the TATA-box binding protein (TBP) in Eukaryotes. MBF1 is absent in Bacteria, but is well- conserved in Eukaryotes and Archaea and harbors a C-terminal Cro-like Helix Turn Helix (HTH) domain, which is the only highly conserved, classical HTH domain that is vertically inherited in all Eukaryotes and Archaea. The main structural difference between archaeal MBF1 (aMBF1) and eukaryotic MBF1 is the presence of a Zn ribbon motif in aMBF1. In addition MBF1 interacting activators are absent in the archaeal domain. To study the function and therefore the evolutionary conservation of MBF1 and its single domains complementation studies in yeast (mbf1Δ) as well as domain swap experiments between aMBF1 and yMbf1 were performed. Results In contrast to previous reports for eukaryotic MBF1 (i.e. Arabidopsis thaliana, insect and human) the two archaeal MBF1 orthologs, TMBF1 from the hyperthermophile Thermoproteus tenax and MMBF1 from the mesophile Methanosarcina mazei were not functional for complementation of an Saccharomyces cerevisiae mutant lacking Mbf1 (mbf1Δ). Of twelve chimeric proteins representing different combinations of the N-terminal, core domain, and the C-terminal extension from yeast and aMBF1, only the chimeric MBF1 comprising the yeast N-terminal and core domain fused to the archaeal C-terminal part was able to restore full wild-type activity of MBF1. However, as reported previously for Bombyx mori, the C-terminal part of yeast Mbf1 was shown to be not essential for function. In addition phylogenetic analyses revealed a common distribution of MBF1 in all Archaea with available genome sequence, except of two of the three Thaumarchaeota; Cenarchaeum symbiosum A and Nitrosopumilus maritimus SCM1. Conclusions The absence of MBF1-interacting activators in the archaeal domain, the presence of a Zn ribbon motif in the divergent N-terminal domain of aMBF1 and the complementation experiments using archaeal- yeast chimeric proteins presented here suggests that archaeal MBF1 is not able to functionally interact with the transcription machinery and/or Gcn4 of S. cerevisiae. Based on modeling and structural prediction it is tempting to speculate that aMBF1 might act as a single regulator or non-essential transcription factor, which directly interacts with DNA via the positive charged linker or the basal transcription machinery via its Zn ribbon motif and the HTH domain. However, also alternative functions in ribosome biosynthesis and/or functionality have been discussed and therefore further experiments are required to unravel the function of MBF1 in Archaea. Reviewers This article was reviewed by William Martin, Patrick Forterre, John van der Oost and Fabian Blombach (nominated by Eugene V Koonin (United States)). For the full reviews, please go to the Reviewer's Reports section.
Permalink | Teilen/Speichern
Wissenschaftliche Texte » Artikel, Aufsatz
Fakultät / Institut:
Fakultät für Chemie » Biofilm Center
Fakultät für Biologie » Genetik
Dewey Dezimal-Klassifikation:
500 Naturwissenschaften und Mathematik » 570 Biowissenschaften; Biologie » 576 Genetik und Evolution
Kollektion / Status:
E-Publikationen / Dokument veröffentlicht
Dokument erstellt am:
Dateien geändert am:
Rechtliche Vermerke:
Marrero Coto et al.; licensee BioMed Central Ltd.
In: Biology Direct 2011, 6:18 // doi:10.1186/1745-6150-6-18